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2-Mercaptoethanol  (2-ME) 1 has  a  beneficial  effect  on  various  cell  culture 
systems. It has been shown to act as a  growth-promoting agent for several cell 
lines (1), it enhances erythropoiesis in vitro (2), and it is able to promote mixed 
lymphocyte culture reactions in serum-free cultures  (3, 4).  2-ME has also been 
shown to enhance the primary immune response in vitro, to substitute function- 
ally for macrophages in this immune response, and to increase cell viability (5, 
6). Recently it was reported that 2-ME can convert a fetal calf serum (FCS) that 
is  unable  to  support  an  in  vitro  primary immune  response  (deficient  serum, 
FCSdef), into an effective FCS (good serum, FCSgood). 2 It was assumed that 2-ME 
activates a  serum component which  is normally present in  FCS.  Moreover,  it 
was demonstrated that 2-ME in association with FCS exerts a  strong mitogenic 
activity on T  cells (7).  Experimental evidence was presented suggesting that 2- 
ME in the presence of FCS can functionally substitute for macrophages in the 
primary immune  response  in  vitro,  because  of this  strong  mitogenicity for T 
cells.  In  this  report  we  will  demonstrate  that  2-ME  does  indeed  activate  a 
component of FCS.  This  2-ME-activated FCS component  acts on lymphocytes 
independently  of free  2-ME  and  is  able  to  substitute  functionally  for  macro- 
phages and complete FCS. 
Materials  and  Methods 
Animals.  Female BALB/c mice (Bomholtgaard, Ry,  Denmark) weighing 20-25 g  were used 
throughout the experiments. The animals received standard diet and water ad libitum. 
Reagents.  Three different batches of FCS were investigated.  One (lot 136; Seromed, Munich, 
Germany) was sufficient in supporting primary immune responses in vitro. Two other batches (lot 
108 and lot 140; Seromed) were not able to support the primary immune responses of normal mouse 
spleen cells. 
2-ME was obtained from Merck-Schuchard,  Darmstadt, Germany, (2-ME for synthesis, 99% 
pure by gas chromatography). Stock solutions,  diluted 1:100 with saline were kept at 4°C. Final 
dilutions  were prepared for each experiment. 
Antigen.  Sheep red blood cells (SRBC) obtained from Behringwerke AG., Marburg,  Germany, 
* Supported  by the Deutsche  Forschungsgemeinschaft  (Sonderforschungsbereich  112, Zellsys- 
temphysiologie). 
1Abbreviations  used in this paper:  BSS, balanced salt solution; FCS, fetal calf serum; MaSF, 2- 
ME-activated  serum factor; 2-ME, 2-mercaptoethanol;  PFC, plaque-forming cells. 
2 Lemke, H., and H. G. Opitz. Manuscript submitted for publication. 
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were stored in sterile Alsever's solution. SRBC were washed twice in balanced salt solution (BSS) 
before use.  107 SRBC in BSS were added to each culture dish. 
Culture of Spleen Cells for Primary Immune Responses.  Spleens were removed under sterile 
conditions and teased with forceps in ice-cold BSS.  After brief sedimentation to remove coarse 
particles, the cell suspension was washed twice in 20 ml of cold BSS and subsequently suspended 
in  culture  medium  (RPMI-1640  medium;  Seromed),  supplemented with  penicillin (100  U/ml), 
streptomycin (100/~g/ml), L-glutamine (2 mM), and 5% FCS. Cell counts and viability testing by 
the dye exclusion method (0.5% trypan blue) were performed in a  Neubauer hemocytometer. 
The primary immunization of cultured spleen cells with SRBC was performed according to the 
method originally described by Mishell and Dutton (8).  The cultures were kept stationary. 
Removal of Macrophages.  Macrophages were removed from spleen cells by the carbonyl iron 
method described by Lundgren et al.  (9).  Carbonyl iron powder (General Aniline & Film Corp., 
New York) was added to 5 ml spleen cell suspension (2  ×  107 nucleated cells/ml) in RPMI-1640 
medium supplemented with  10% FCS in Petri dishes (65 mm diameter,  Greiner tissue culture 
dishes). Cells were incubated at 37°C for 30 rain in an atmosphere containing 5% CO~ and those 
adherent to or containing iron particles were removed with a magnet. The cells were subsequently 
washed twice  in BSS and suspended in culture  medium.  Macrophage  depletion with the iron 
treatment reduced the number of macrophages by 90-95% (8). 
Preparation of 2-ME-Activated Serum Factor (MaSF).  FCS was incubated with 10 -3 M 2-ME 
for 24 h  at room temperature and lyophilized in a  WKF L 05 lyophilisator at -20°C.  Lyophilized 
FCS  (5  ml) dissolved in 2  ml of distilled water was  fractionated on a  0.8  ×  60 cm column of 
Sephadex G-100 equilibrated with 0.05 M Tris-HCl/0.1 M NaCI, pH 7.5 and eluted at a flow rate of 
15 ml/h. The elution profile of this material was measured by optical density at 280 nm. Ferritin 
(tool wt 460,000), bovine serum albumin (tool wt 67,000), ovalbumin (tool wt 45,000), chymotrypsin 
(tool  wt  25,000),  and myoglobin  (tool  wt  17,800)  served  as  markers.  Fractions of 5.7  ml  were 
lyophilized, dissolved in 2 ml of distilled water, dialyzed against RPMI-1640 medium, and steri- 
lized by Millipore filtration before use in tissue culture. Various volumes of the single fractions 
were added to the spleen cell cultures and the concentration expressed as percentage of the final 
volume of the culture. 
Absorption of MaSF.  Packed spleen cells or SRBC  (0.5 ml) were incubated with 2 ml of the 
fraction containing MaSF for 1 h at 4°C. After centrifugation the supernates were tested for MaSF 
activity in the Mishell-Dutton system. 
Assay of  Antibody Synthesis.  On day 5 of culture a modified hemolytic plaque assay was used 
to quantitate the antibody production in vitro (10).  0.6 ml of 0.5% agar (Difco Bacte Agar; Difco 
Laboratories,  Detroit,  Mich.)  in BSS with  0.05%  DEAE  dextran  (Pharmacia  Fine  Chemicals, 
Uppsala,  Sweden) was kept at 46°C,  and 0.05 ml of packed SRBC diluted 1:8 in BSS,  0.1  ml of 
washed spleen cells harvested from the culture, and 0.05 ml of guinea pig serum (diluted 1:4 in 
BSS) were added. The mixture was plated on plastic Petri dishes and incubated for 2 h at 37°C. The 
data obtained are expressed as plaque-forming cells (PFC) per culture. 
Results 
Effect of 2-ME on Antibody Synthesis In Vitro.  The experiments summa- 
rized in Table I show the effect of three different FCS batches on the primary 
immune response  of cultured normal  and  macrophage-depleted spleen  cells. 
FCS3 is able to support the anti-SRBC-PFC response, whereas FCS~ and FCS2 
fail to stimulate the immune response of normal spleen cells. However, when 2- 
ME at a final concentration of 5  ×  10 -5 M is added to the cultures an immune 
response with FCS1  and FCS2  is  also obtained.  The yield of anti-SRBC-PFC 
obtained with FCS3 is improved after addition of 2-ME. In macrophage-depleted 
spleen cell cultures no immune response is obtained, regardless of  the FCS used. 
After  addition  of 2-ME  to  the  macrophage-depleted spleen  cell  cultures  an 
immune response is recovered with all three FCS batches, although it appears 
that the achievable PFC level is dependent upon the quality of the FCS. 
Activation of a Serum Component  by 2-ME.  To decide whether 2-ME acts Addi- 
Type of spleen cells  tion of  2- 
ME 
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TABLE  I 
Effect of Three Different FCS on the Primary A nti-SRBC Response of Spleen  Cell Cultures 
Anti-SRBC PFC/culture 
FCS~  FCS2  FCSs 
Exp. 1  Exp. 2 
Normal spleen cells  <100  <100 
Normal spleen cells  +  2,170_+140 1,830_+220 
Macrephage-depleted  <100  <100 
spleen cells 
Macrephage-depleted  +  1,730_+195  1,590_+160 
spleen cells 
Exp. 1  Exp. 2  Exp. 3 
<100  <10~  <100 
3,350-+210  3,800-+264  2,900_+230 
<100  <100  <10O 
2,760_+184  3,270_+260  2,040_+310 
Exp. 1  Exp. 2  Exp. 3 
3,970_+180  4,100_+264  4,400_+310 
5,260_+370  6,120_+290  5;850_+420 
<100  <100  <100 
4,950_+240  5,350_+430  5,200-+530 
The anti-SRBC PFC response was measured on day 5. The anti-SRBC PFC response of unstimulated cultures did not exceed 300 PFC per 
culture.  The data represent the mean of triplicate  cultures  -+ SE. 
TABLE II 
Interaction  between 2-ME and FCS 
Treatment of FCS before use in the 
Mishell-Dutton  system 
Anti-SRBC PFC/culture 
FCSz  FCS2 
Untreated (1) 
Incubated with 2-ME (2) 
Untreated, lyophilized (3) 
Incubated with 2-ME, lyophilized (4) 
<100  <100 
5,450 _+ 470  2,970 _  360 
<100  <100 
4,970 _+ 620  2,570 ___ 480 
FCS  (5%) untreated or incubated with  10  -3 M 2-ME for 24 h was used either directly or after 
removal of free 2-ME by lyophilization.  PFC  response  was measured on day 5 in spleen cell 
cultures depleted of adherent cells. The data represent the mean of triplicate cultures _  SE. 
directly on spleen cells or indirectly via a serum component, FCS was incubated 
with 10 -3 M 2-ME for 24 h at room temperature. This concentration was found to 
be optimal for the activation of FCS, at 10  -2 M strong inhibition occurred while 
at 10 -5 M no activation was observed. Thereafter, one half of the FCS containing 
2-ME was tested directly while the other one was lyophilized before use in the 
primary immune response in vitro. Unbound 2-ME is completely removed by the 
lyophilization  procedure.  The  lyophilized  material  was  dissolved  in  distilled 
water to  its  initial  volume and  its  effect on the  antibody synthesis  of macro- 
phage-depleted spleen cells was examined.  The results  are shown in Table II. 
The  same  FCS  not  treated  with  2-ME  was  not  sufficient  for  an  antibody 
synthesis  by macrophage-depleted  spleen  cells,  whether  it  was  lyophilized  or 
not. The ability of 2-ME-treated FCS to support a  primary immune response in 
macrophage-depleted spleen cells,  however, remains unchanged  after lyophili- 
zation. This shows that no free 2-ME is necessary for the cell culture once it has 
reacted with FCS. 
Fractionation of 2-ME-Treated FCS on Sephadex G-I O0.  Gel filtration of 2- 
ME-treated FCS on Sephadex G-100 resulted in the elution profile shown in Fig. 
1.  The  area containing  the  active component is  marked by a  horizontal  line. 
Untreated  FCS,  when separated  over Sephadex G-100,  did not  show a  macro- 
phage-replacing activity in any fraction.  Table III shows the effect of different 
concentrations  of the active fraction on the antibody synthesis of macrophage- 
depleted spleen cells.  Increasing amounts of the factor lead to increased  anti- 
body synthesis  which  reached  a  plateau  at  20%  MaSF.  Moreover,  MaSF  im- 1032 
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FIO.  1.  Elution profile of 2-ME-treated FCS, separated on Sephadex G-100. The horizontal 
line indicates the area containing MaSF. 
TABLE  III 
Dose Response of the Sephadex G-IO0 Separated 2-ME-Activated Serum Component 
Anti-SRBC PFC/culture  No. viable cells/culture (× l05)  Addition of Seph- 
adex G-100 frac-  Serum factor  Serum factor  tion 
Activated  Nonactivated  Activated  Nonactivated 
% 
1  160 _+ 45  <100  12  <10 
5  180 _+ 38  <100  14  <10 
10  4,780 _+ 620  <100  24  <10 
20  7,450 -+ 530  <100  39  16 
30  6,970 _+ 480  <100  42  17 
Control 
5% FCS  <100 
5% FCS + 2-ME  5,370 _+ 540 
(10  -5 M) 
FCS2 treated with or without 2-ME (10  -~ M) was separated on Sephadex  G-100 column. Different 
concentrations of active fraction were added  to  107 macrophage-depleted  spleen cells.  PFC and 
viability were determined on day 5. The results indicate the mean of triplicate cultures +_ SE. 
proves cell viability in the cultures and resembles in that respect, the effect of 2- 
ME added to spleen cell cultures directly. Additional experiments showed that 
the serum component activated by 2-ME is resistant to heating to 56°C for 30 
min.  A  temporary  variation of the  pH  value to  pH  4  had  also  no  effect  on 
activity. No loss of activity was observed after storage at 4°C for more than 2 wk. 
Determination of MaSF in Three Different Batches of FCS.  The following 
experiment was designed to determine whether a  correlation exists between the 
efficacy  of  an  FCS  in the  Mishell-Dutton culture  system  and  its  content of OPITZ, OPITZ, LEMKE, HEWLETT, SCHREML, AND FLAD  1033 
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FIG.  2.  Dose-response  curves of MaSF preparations from two deficient FCS (FCS1, FCS~) 
and one good FCS  (FCS3):  FCS1,  (×-.-x);  FCS2  (C---O);  FCS3  (O-O).  The experimental 
data were analyzed for linear regression  on a Wang 600 calculator; correlation coefficients 
were: FCS~, 0.98;  FCS2, 0.98;  and FCS3, 0.95. 
MaSF. In order to assess MaSF concentrations, identical volumes of each batch 
of  2-ME-treated FCS were chromatographed over a Sephadex G-100 column. The 
MaSF-containing fractions were added to macrophage-depleted spleen cell cul- 
tures in final concentrations as shown in Fig. 2. In these experiments the spleen 
cell cultures were supplemented with 5% FCS. The doses resulting in maximal 
stimulation for MaSF-FCS1 was 40% (vol/vol), for MaSF-FCS2 20% (vol/vol), and 
for MaSF-FCS3 10% (vol/vol). The number of PFC per culture was similar for all 
three MaSF preparations at these concentrations, i.e., higher concentrations did 
not increase the response. 
Activity of MaSF in the In Vitro Humoral Immune Response in the Presence 
or Absence  of FCS.  In the previous experiment 5%  FCS was present in the 
culture medium in addition to the MaSF-containing fraction, and the cultures 
were  fed  daily with  a  FCS-containing mixture  as  described by  Mishell  and 
Dutton (8). The following experiments were performed to investigate the activ- 
ity of MaSF in  normal  and  macrophage-depleted spleen cell  cultures in the 
absence of additional FCS. As shown in Table IV, MaSF isolated from FCS2 and 
FCS3 gave an optimal response when present at a concentration of 20% vol/vol or 
10% vol/vol, in the presence or absence of additional homologous FCS. Further 
addition of 2-ME to the MaSF-containing fraction had no effect on the antibody 
synthesis. This experiment demonstrates that the MaSF-containing serum frac- 
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TABLE IV 
Effect of MaSF on the PFC Response of Normal and Macrophage-Depleted  Spleen Cells 
Without Additional FCS 
Type of  spleen cells 
Culture conditions 
FCS2  FCS2 +  2-ME  MaSF +  FCS~  MaSF  MaSF +  2-ME 
Normal spleen cells  <100  3,350 ±  410  7,670 ±  1,320  8,180 ±  520  7,950 ±  1,020 
Maerophage-depleted  <100  2,760 ±  395  9,320  ±  860  7,770 ±  670  7,560 ±  840 
spleen cells 
FCS3  FCS3 +  2-ME  MaSF +  FCSa  MaSF  MaSF +  2-ME 
Normal spleen cells  2,890 ±  410  4,260 ±  370  6,350 ±  530  6,960 ±  470  7,260 ±  730 
Macrophageodepleted  <100  3,870 ±  420  5,970  ±  460  6,330 ±  560  5,750 ±  370 
spleen cells 
Normal or macrophage-depleted spleen ceils were incubated with 5% FCS, 5% FCS + 2-ME (10  -B M), 20% MaSF + 5% FCS, or 20% 
MaSF with or without addition of 2-ME (10  -5 M). FCS-containing cultures were fed with FCS while MaSF-containing cultures were 
fed with MaSF. The number of PFC of unstimulated cultures did not exceed 320 _+ 45 PFC per culture. PFC response was measured 
on day 5. The data represent the mean of triplicate cultures ±  SE. 
SRBC without additional FCS in the culture medium and also to replace the 
function of macrophages. 
MaSF Addition to, or Removal from Macrophage-Depleted Spleen Cell Cul- 
tures at Various Times.  The following experiments were designed to investi- 
gate the period of contact between MaSF and macrophage-depleted spleen cells 
required for an optimal immune response. The cultures received an optimal dose 
of MaSF at various times after initiation of  the culture. PFC were determined on 
day 5. Table V shows that MaSF has to be added during the first 24 h of culture 
in order to obtain a  PFC  response.  At later intervals the  addition of MaSF 
becomes ineffective. The viability of cultured cells determined by dye exclusion 
also  correlates  with the  time  of addition of MaSF.  The  duration of contact 
between  MaSF  and  spleen  cells  required  for  an optimal  PFC  response  was 
studied by removing MaSF  at  various times  after initiation of the  culture. 
Control  cultures  were  subjected  to  the  same  washing procedure,  but  were 
immediately reconstituted with the original MaSF-containing medium. As can 
be seen from Table VI, MaSF has to be present during the first 72 h of culture to 
obtain an optimal PFC  response;  if MaSF  is removed within 72  h,  no,  or  a 
suboptimal, response is observed. 
Absorption  of MaSF-Activity  by  Spleen  Cells.  After incubating a  MaSF- 
containing fraction with packed spleen cells or SRBC the supernate was tested 
for its MaSF activity in macrophage-depleted spleen cell cultures. As shown in 
Table VII,  MaSF activity is reduced to about 30%  of the original activity by 
packed spleen cells. No activity is lost after absorption with SRBC. 
Discussion 
In the present study, the mode of action of 2-ME as a macrophage substitute in 
the primary immune response against SRBC in vitro was further analyzed. The 
following results were obtained: 
(a)  It is confirmed that 2-ME can support a PFC response in cultures supple- 
mented with deficient FCS in normal or macrophage-depleted spleen cell cul- 
tures. FCS and 2-ME are both essential (Table I): 
(b)  The active component is not 2-ME itself  but a serum factor activated by 2- OPITZ,  OPITZ, LEMKE,  HEWLETT,  SCHREML,  AND  FLAD  1035 
TABLE V 
Effect of Adding MaSF to Macrophage-Depleted Spleen  Cells at Various Times after 
Initiation of Culture 
Time of adding MaSF (hours after initiation of culture) 
Not 
0  24  48  72 
added 
Anti-SRBC PFC/culture 
Exp. 1  8,160 ± 260  7,090 __+_ 430  510 -+ 80  <100  <100 
Exp. 2  7,690 ± 570  7,480 ± 370  815 -+ 140  <100  <100 
Viable  cell  recovery  at 
day 5 
Exp. 1  46%  37%  22%  10%  <1% 
MaSF/FCS2, 20% voi/vol was added to macrophage-depleted spleen cell cultures at various times. 
All cultures were supplemented  with 5% FCS2 from  the beginning.  The data represent the mean of 
triplicate cultures ± SE. 
ME  (Table II). The serum factor is altered by 2-ME in such a  way that it can 
completely replace the function of macrophages in terms of supporting a  pri- 
mary anti-SRBC PFC response and promoting good cell viability in the culture 
(Table III). MaSF can be separated from the bulk of serum proteins of  FCS by gel 
filtration on Sephadex G-100. The factor appears to have a molecular weight in 
the order of that of ovalbumin (Fig. 1). 
(c)  FCSgood  can be distinguished from FCSdef by their different concentrations 
of MaSF. From the slopes of  the dose-response curves (Fig. 2) it can be seen that 
the quality of the response is similar in all three FCS lots. From this result it 
can  be  deduced that  only the  concentration of this  factor is  critical  for the 
efficacy of a particular FCS lot in a primary humoral immune response in vitro. 
(d)  FCS is no longer necessary when the cell culture medium is supplemented 
with optimal amounts of MaSF.  The response cannot be increased by further 
addition of FCS  or  2-ME  to the  cell  culture.  Therefore an  in vitro  immune 
response can be elicited from a macrophage-depleted, FCS-free system, i.e. from 
a  system consisting of spleen  lymphocytes, SRBC,  and  MaSF.  An  inherent 
feature  of MaSF-supplemented  cultures  is  the  improved  viability of spleen 
lymphocytes. MaSF also reduces the variability of the anti-SRBC PFC response 
normally found in the Mishell-Dutton culture system. 
(e)  MaSF needs to be added within the first 24 h of culture and should remain 
in  contact  with  the  spleen  cells  for  at  least  72  h  to  enable  spleen  cells  to 
synthesize antibodies. When MaSF is incubated with SRBC no loss of activity is 
observed, whereas a  loss of activity does occur after incubation of MaSF with 
spleen cells. This suggests a  specific interaction of MaSF with spleen cells. 
Recently it was reported that 2-ME could not replace the function of macro- 
phages when they were removed by passage through columns of Sephadex G-10 
or by high concentrations of carbonyl iron (11, 12). We have investigated the 
depletion of macrophages by carbonyl iron in detail (7). In our hands carbonyl 
iron reduced the concentration of macrophages in spleen cells by 90-95%.  Even 
in the  presence  of silica,  macrophage-depleted spleen  cells  exhibited  a  PFC 
response to SRBC when 2-ME was added. The difference between these findings 1036  2-MERCAPTOETHANOL-ACTIVATED  SERUM  FACTOR 
TABLE  VI 
Effect of Removing MaSF from the Spleen Cells at Various  Times of Culture 
Treatment 
Time of  treatment (hours after  culture)  anti-SRBC PFC/culture 
0  24  48  72  96 
Removal of MaSF  0  0  1,680 -+ 460  4,320 -+ 530  6,760 -+ 420 
Remove  and  add  back  5,780 -+ 610  6,120 -+ 310  4,860 ±  280  5,430 -+ 660  6,780 -+ 430 
MaSF immediately 
Macrophage-depleted  spleen cells stimulated  with SRBC  were cultured with MaSF/FCS2  (20% vol/vol) on day 0 and then 
transferred at various times to fresh medium  + 5% FCS~. The data represent the mean of  triplicate  cultures -+ SE. 
probably results from the methods used: it is possible that by certain methods, 
other  cells  in  addition  to  macrophages  are  removed  and  therefore  the  PFC 
response is inhibited in a  way that cannot be abrogated by 2-ME. 
Macrophages  have  been  considered  to  be  essential  for  the  induction  of a 
primary immune response in vitro against thymus-dependent  antigens  (6,  13, 
14), although direct contact between macrophages and B cells is not necessary 
(15). It has also been shown that macrophage-derived factors are able to replace 
this macrophage function (16-18), but only in the presence of FCS. 
MaSF permits  a  humoral  immune  response in macrophage-depleted  spleen 
cultures,  i.e.,  MaSF can completely replace macrophage function in these cul- 
tures. On the basisof similar results with 2-ME Chen and Hirsch suggested that 
a "2-ME-like substance" was the active factor enabling macrophages to activate 
lymphocytes in the Mishell-Dutton culture system (6). Based on our experimen- 
tal data it is suggested that 2-ME or macrophages act on lymphocytes indirectly, 
i.e.,  through the activation of a  serum component. The following observations 
support this  conclusion.  It has been shown that  the  addition  of 2-ME  to the 
Mishell-Dutton cultures permits an optimal immune response; the presence or 
absence  of suboptimal  or optimal  numbers  of macrophages  in  the  culture  is 
irrelevant  (6),  probably 2-ME  is able to activate  the  serum  factor faster  and 
more efficiently than macrophages. This effect of 2-ME is also seen in its ability 
to activate  FCS~ef in normal  Mishell-Dutton  cultures, 2 whereas macrophages 
permit a response only if a "good" serum is present, i.e., one that contains a high 
concentration of nonactivated serum factor (Fig. 2). A further argument in favor 
of this model is the finding that in the primary in vitro antibody response both 2- 
ME and macrophages act on T cells (7,  19). 
Many factors have been described that, like MaSF, can replace macrophages 
in in vitro antibody synthesis (16-18). These factors can be distinguished from 
MaSF: they are actively synthesized by macrophages and are released into the 
medium, they can be produced in the absence of FCS, and can be absorbed by 
SRBC (16). The fact that they can functionally substitute for macrophages in in 
vitro antibody synthesis only in medium containing  FCS suggests that  these 
factors may be activators of the serum factor described in this report. 
The  activity  of 2-ME,  macrophages  or  macrophage  factors  in  the  in  vitro 
antibody synthesis may be explained by the hypothesis that they are  able to 
activate a component of FCS which, in its activated form, is essential for the in 
vitro humoral immune response. OPITZ,  OPITZ,  LEMKE,  HEWLETT,  SCHREML,  AND  FLAD 
TABLE VII 
Absorption  of MaSF by Spleen Cells or SRBC 
1037 
Treatment of MaSF 
Addition of  Anti-SRBC PFC/cul- 
supernate  ture 
(%, vol/vol) 
MaSF fraction absorbed with spleen cells  20  1,080 ±  240 
40  3,120 ±  330 
MaSF fraction absorbed with SRBC  20  5,630 ±  720 
40  8,790 ±  810 
MaSF fraction control  20  5,020  ±  470 
40  10,410  _  620 
2 ml MaSF/FCS1 were incubated with 0.5 ml packed spleen cells or SRBC at 4°C for 1 h. Different 
concentrations of MaSF were added to macrophage-depleted spleen cells. Cultures did not receive 
additional FCS. PFC response was measured on day 5. The data represent the mean of triplicate 
cultures ±  SE. 
Summary 
The  mode of action of 2-mercaptoethanol  (2-ME)  on the  primary immune 
response in vitro was investigated. Fetal calf serum  (FCS) was preincubated 
with 2-ME and lyophilized to remove free 2-ME.  This 2-ME-treated FCS was 
able to substitute the function of adherent cells in the primary immune response 
against sheep red blood cells  (SRBC)  in vitro.  Fractionation of 2-ME-treated 
FCS on a Sephadex G-100 column showed that 2-ME acted on a high molecular 
serum component which after activation, could substitute for macrophages. In 
order to obtain a humoral immune response against SRBC in vitro, spleen cells 
require selected FCS. These "good" sera could be distinguished from "deficient" 
sera by their higher content of this 2-ME-activated factor. The height of the in 
vitro immune response to SRBC  was dependent on the  amount of activated 
factor  added  to  the  culture  medium.  FCS  normally required  in the  culture 
medium could be completely replaced by the factor-containing fraction without 
deleterious effect on the culture. The factor should be added to the spleen cells 
during the first 24 h  of culture and remain there for 72 h  in order to obtain an 
optimal immune response. The factor could be partially absorbed by spleen cells 
but not by SRBC.  The relationship between macrophage, 2-ME,  and FCS in 
eliciting an in vitro primary immune response is discussed. 
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